To assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD8233 after multiple dose administration in subjects with dyslipidemia

Trial Identifier: D7990C00002
Sponsor: AstraZeneca
Collaborator:
Parexel International
NCTID:: NCT04155645
Start Date: November 2019
Primary Completion Date: June 2021
Study Completion Date: June 2021
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
United States of America, CA Chula Vista, CA, United States of America, 91911
United States of America, CA Glendale, CA, United States of America, 91206
United States of America, CA La Mesa, CA, United States of America, 91942
United States of America, FL Jacksonville, FL, United States of America, 32216
United States of America, FL Orlando, FL, United States of America, 32806
United States of America, FL Port Orange, FL, United States of America, 32127
United States of America, MD Brooklyn, MD, United States of America, 21225